Storia in 2 fonti

Saptalis Pharmaceuticals Launches Cyclosporine Ophthalmic Emulsion 0.05% and Expands Product Portfolio

Raccontata da

morningstar.com

healio.com

Confronto fonti

2 prospettive sulla stessa storia

AI · summaries

morningstar.comStai leggendo11 g fa

Saptalis Pharmaceuticals Launches Cyclosporine Ophthalmic Emulsion 0.05% and Expands Product Portfolio

Saptalis launches Cyclosporine 0.05% emulsion (single-use vials) for dry eye, expands portfolio across dermatology, psychiatry, allergy. Specialty pharma consolidates liquid/semi-solid dosages with U.S. manufacturing, signals market shift from generics toward branded innovation.

originale

healio.com10 g fa

Saptalis launches cyclosporine ophthalmic emulsion 0.05% for dry eye

Saptalis Pharmaceuticals launched generic cyclosporine ophthalmic emulsion 0.05% for the treatment of dry eye disease, according to press release.According to the release, the eye drop, a generic of Restasis…

Saptalis Pharmaceuticals Launches Cyclosporine Ophthalmic Emulsion 0.05% and Expands Product Portfolio

Saptalis launches cyclosporine ophthalmic emulsion 0.05% for dry eye

Timeline cronologica

Saptalis Pharmaceuticals Launches Cyclosporine Ophthalmic Emulsion 0.05% and Expands Product Portfolio

Saptalis launches cyclosporine ophthalmic emulsion 0.05% for dry eye